Weight loss ‘wonder drug’ semaglutide can cut down risk of heart disease, says Danish drugmaker
Novo Nordisk says results of its trials show a 2.4 mg dose can cut down major heart-related ailments by 20%, and the study will be published in a peer-reviewed journal by end of year. Key Points
ThePrintMounjaro vs. Ozempic: Which has worse side effects?
Users of weight-loss drugs like Ozempic and Wegovy often experience common side effects like nausea and diarrhea. Competitor Mounjaro may cause similar but milder symptoms. Key Points
InsiderWegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths. Key Points
WIREDOzempic, the Hollywood weight-loss drug, now popular with NYC rich
Ozempic and Wegovy are a hit with Hollywood celebrities. Now, injectable weight-loss drugs are conquering the ranks of the Upper East Side rich. Key Points
InsiderIt’s the brain, not the gut! What new findings reveal about semaglutide weight-loss drug
Semaglutide mimics GLP-1 hormone released by gut after eating, which attaches itself to GLP-1 receptors in the body. Activated receptors help reduce blood sugar and curb appetite. Key Points
ThePrintAvoid weight gain after Ozempic with 'maintenance dose': Doctor
Weight gain is a common experience among people who stop taking Ozempic. One doctor is experimenting with tapering off slowly to keep weight low. Key Points
InsiderOzempic helped me lose weight I'd been struggling with: Doctor
A doctor who prescribes weight loss drugs started taking a version of Ozempic a year ago. He's hoping it'll help him keep the weight off for good. Key Points
InsiderThe Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders. Key Points
WIREDThe Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders. Key Points
WIREDOzempic for weight loss: Pills coming, but they may not be convenient
People who took a new, oral version of semaglutide had near-identical weight loss results compared to injections. But the pills could be a hassle. Key Points
Insider
Popular weight-loss drug found to ease arthritis pain
A groundbreaking study shows that the weight-loss drug semaglutide can significantly reduce knee pain from obesity-related arthritis, offering a new non-opioid option for pain relief. However, experts warn of potential challenges such as weight regain after stopping the drug and its high cost. Key Points
India TodayOzempic made woman's cravings and 'food noise' disappear
"Semaglutide has changed my life and I hope it's around forever," Staci Rice said. "It's been a miracle for me." Key Points
InsiderHow Ozempic grew to become a celebrity buzzword
Trending for a while now, with over 147k tags on Instagram, the ‘miracle’ drug may have more than a few side effects. Here’s a deep dive. Key Points
Hindustan TimesHow well-off Brits still buy Ozempic online for weight loss
John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator. Kim Gradwell, a retired receptionist who developed type 2 diabetes nearly 20 years ago, isn't sure where she'll find her next dose. Key Points
ReutersHow well-off Brits still buy Ozempic online for weight loss
John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator. Kim Gradwell, a retired receptionist who developed type 2 diabetes nearly 20 years ago, isn't sure where she'll find her next dose. Key Points
ReutersDon't skip WeGovy, Ozempic during the holidays, doctors say
People taking WeGovy or Ozempic for weight loss are considering skipping a week to eat more on Thanksgiving. But doctors say that could be dangerous. Key Points
InsiderWegovy reduces risk of heart attacks, strokes, and death by up to 20%, new study finds
A large global study found that weight-loss drug Wegovy reduced the risk of major cardiovascular issues. It could prompt insurers to cover the drug. Key Points
Insider